Stockscreener 앱 받기
2.08
5.45%
-0.12
전일 마감가:
$2.20
열려 있는:
$2.19
하루 거래량:
1.05M
Relative Volume:
0.09
시가총액:
$71.64M
수익:
-
순이익/손실:
$-20.34M
주가수익비율:
-2.9842
EPS:
-0.697
순현금흐름:
$-15.59M
1주 성능:
-13.33%
1개월 성능:
-39.53%
6개월 성능:
+63.78%
1년 성능:
-2.80%
1일 변동 폭
$2.06
$2.24
1주일 범위
$2.06
$2.60
52주 변동 폭
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
2.08 | 75.78M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | 개시 | H.C. Wainwright | Buy |
| 2025-10-31 | 개시 | Roth Capital | Buy |
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - Улправда
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
About Us - FinancialContent
How HeartBeam Inc. stock performs in interest rate cyclesQuarterly Market Review & Fast Entry High Yield Stock Tips - Улправда
Will HeartBeam Inc. stock benefit from automationQuarterly Market Summary & Technical Entry and Exit Tips - ulpravda.ru
Is HeartBeam Inc. Equity Warrant stock safe for conservative investorsMarket Growth Review & Accurate Entry/Exit Alerts - Улправда
What sentiment indicators say about HeartBeam Inc. stock2025 Technical Overview & Short-Term Trading Alerts - Улправда
Can HeartBeam Inc. Equity Warrant stock outperform in 2025 bull marketQuarterly Trade Report & Stepwise Trade Signal Guides - Улправда
Is HeartBeam Inc. Equity Warrant stock a safe haven assetRecession Risk & Short-Term High Return Strategies - Улправда
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
AeroVironment Stock Surges: Military Gains Explored - StocksToTrade
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Retail Activity & Daily Market Momentum Tracking - ulpravda.ru
Can HeartBeam Inc. stock hit analyst price targetsGap Fill Strategies & Low Risk Capital Growth - Улправда
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
HeartBeam (NASDAQ: BEAT) to attend JP Morgan 2026 annual healthcare conference - MSN
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - TradingView — Track All Markets
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - 01net
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - FinancialContent
Trend Recap: Is HeartBeam Inc stock recession proofMarket Trend Review & Weekly Watchlist for Consistent Profits - moha.gov.vn
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Major HeartBeam Investor Makes Bold Move With Eye-Catching Stock Sale - TipRanks
Heartbeam Insider Sold Shares Worth $895,000, According to a Recent SEC Filing - marketscreener.com
Earnings Beat: How institutional buying supports Alector Inc stock2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will HeartBeam Inc. stock deliver shareholder value2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
How HeartBeam Inc. stock performs in stagflation2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Trend Report: Will HeartBeam Inc. stock deliver shareholder valueMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Can HeartBeam Inc. stock double in next 5 yearsWeekly Profit Recap & Step-by-Step Trade Execution Guides - Улправда
Patterns Watch: Can HeartBeam Inc. stock hit analyst price targetsPortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
HeartBeam Director George de Urioste Sells All Common Stock Holdings - TradingView — Track All Markets
How risky is HeartBeam Inc. Equity Warrant stock nowJuly 2025 Decliners & Expert Verified Movement Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
How institutional buying supports HeartBeam Inc. Equity Warrant stockPrice Action & High Accuracy Investment Signals - Улправда
Why HeartBeam Inc. Equity Warrant stock is a must watch in 2025Gap Up & Daily Entry Point Trade Alerts - DonanımHaber
Is HeartBeam Inc. stock dividend yield sustainable2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
Will HeartBeam Inc. Equity Warrant stock deliver consistent dividendsWeekly Profit Summary & Stepwise Trade Signal Guides - DonanımHaber
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - Digital Journal
HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - NewMediaWire
HeartBeam (NASDAQ: BEAT) ranks second worldwide in 12-lead ECG innovation - MSN
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Market Trend Summary & Precise Trade Entry Recommendations - Улправда
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Heartbeam Inc 주식 (BEAT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| de Urioste George | Director |
Dec 18 '25 |
Sale |
2.83 |
33,185 |
93,914 |
0 |
| de Urioste George | Director |
Dec 17 '25 |
Sale |
3.68 |
23,961 |
88,176 |
33,185 |
| Ferrari Richard | Director |
Feb 14 '25 |
Buy |
1.70 |
29,412 |
50,000 |
179,136 |
| Cruickshank Tim | CFO |
Feb 14 '25 |
Buy |
1.70 |
17,647 |
30,000 |
17,647 |
3.21%
2.88%
자본화:
|
볼륨(24시간):